Dissecting SUMO Activating Enzyme Pathways to Inform Therapy

剖析 SUMO 激活酶途径以指导治疗

• 批准号: MR/X001008/1
• 负责人: Joanna Morris
• 金额: $ 93.14万
• 依托单位: University of Birmingham
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FX001008%2F1
• 关键词: Dissecting; SUMO; Activating; Enzyme; Pathways

One cell becomes two by dividing its DNA, in packets of chromosomes, into two daughter cells. This process is supported by a tiny protein that is added to other proteins to help the packets divide correctly. Correct DNA division is particularly important in some cancers that are driven by a particular genetic change, called Myc amplification. New drugs that stop the small protein from being added appear to be useful in killing cancers that have this genetic change. We have recently discovered that the target of those drugs behaves in surprising ways. Instead of having a single role as previously thought, we find it has at least two different functions; one of these is in the poorly understood process of helping DNA remain undamaged as it is divided into the daughter cells. Our aims in this project are to investigate how the drug target behaves in these different ways, to find out which one of them is most important in supporting cancer cell survival, and to discover how it works to prevent DNA damage. This work has implications for how the new drugs are used to help cancer patients.

一个细胞分裂成两个细胞，通过分裂它的DNA，在染色体包，成两个子细胞。这个过程由一种微小的蛋白质支持，这种蛋白质被添加到其他蛋白质中，以帮助包正确分裂。正确的DNA分裂在一些由特定遗传变化（称为Myc扩增）驱动的癌症中尤为重要。阻止这种小蛋白被添加的新药似乎有助于杀死具有这种遗传变化的癌症。我们最近发现，这些药物的靶点以令人惊讶的方式发挥作用。我们发现它至少有两种不同的功能，而不是像以前认为的那样具有单一的作用;其中之一是在帮助DNA在分裂成子细胞时保持不受损伤的过程中。我们在这个项目中的目标是研究药物靶点如何以这些不同的方式发挥作用，找出其中哪一个在支持癌细胞存活方面最重要，并发现它如何防止DNA损伤。这项工作对如何使用新药来帮助癌症患者具有重要意义。